Ataxia Telangiectasia News and Research

RSS
Ataxia-telangiectasia (A-T) is a primary immunodeficiency disease which affects a number of different organs in the body. An immunodeficiency disease is one that causes the immune system to break down, making the body susceptible to diseases. It is a rare, recessive genetic disorder of childhood that occurs in between 1 out of 40,000 and 1 out of 100,000 persons worldwide. The ailment is progressive. Patients with A-T are frequently wheelchair-bound by their teens, and the disease is generally fatal to patients by the time they reach their twenties.
Merck and CNIO sign agreement to collaborate in area of cancer drug development

Merck and CNIO sign agreement to collaborate in area of cancer drug development

Merck signs license agreement with CNIO for cancer drug development

Merck signs license agreement with CNIO for cancer drug development

Specific types of intestinal bacteria are major contributors to lymphoma

Specific types of intestinal bacteria are major contributors to lymphoma

Novel drug may increase the effectiveness of radiation therapy for brain cancer

Novel drug may increase the effectiveness of radiation therapy for brain cancer

Disease-in-a-dish models show promise for treating ataxia telangiectasia

Disease-in-a-dish models show promise for treating ataxia telangiectasia

Research discovery may lead to effective new treatments for neurodegenerative disease

Research discovery may lead to effective new treatments for neurodegenerative disease

DLKI-DIO3 miRNA cluster suppresses spread of cancer from its primary site

DLKI-DIO3 miRNA cluster suppresses spread of cancer from its primary site

Scientists discover new signalling pathway that controls both obesity and atherosclerosis

Scientists discover new signalling pathway that controls both obesity and atherosclerosis

Researchers determine structure of MRN complex

Researchers determine structure of MRN complex

TopBP1 protein prevents early brain cells from DNA damage

TopBP1 protein prevents early brain cells from DNA damage

Human diseases with Drosophila counterparts discussed at annual conference

Human diseases with Drosophila counterparts discussed at annual conference

NYUCI experts present latest research findings about hematologic cancers at 53rd ASH meeting

NYUCI experts present latest research findings about hematologic cancers at 53rd ASH meeting

Caffeine in sunscreens may protect from skin cancer: Study

Caffeine in sunscreens may protect from skin cancer: Study

Jeffrey Modell Foundation opens new center for primary immunodeficiency

Jeffrey Modell Foundation opens new center for primary immunodeficiency

Cancer-causing retrovirus prolongs survival of host cells

Cancer-causing retrovirus prolongs survival of host cells

Study reveals how MMSET gene enables disease-causing mutations to occur

Study reveals how MMSET gene enables disease-causing mutations to occur

Discovery reveals a new approach to target cancer

Discovery reveals a new approach to target cancer

Breast cancer survivors at increased risk of developing second cancer: Study

Breast cancer survivors at increased risk of developing second cancer: Study

Global Genes Project: World Rare Disease Day 2010, a tremendous success

Global Genes Project: World Rare Disease Day 2010, a tremendous success

ATM tumor-suppressor also recognizes damage caused by ROS and orders autophagy

ATM tumor-suppressor also recognizes damage caused by ROS and orders autophagy